Original Article

Few Patients Are Treated for Both Obesity and Depression

Authors: Elizabeth Pfoh, PhD, MPH, Ning Guo, MS, Michael Rothberg, MD, MPH

Abstract

Objectives: Understanding the epidemiology of treatment for patients with co-occurring depression and obesity can inform care quality. The objective of the study was to identify how patients with obesity and newly diagnosed depression are treated and whether treatment is associated with body mass index change.

Methods: This cohort study included adults with obesity and newly diagnosed depression who had ≥2 primary care visits between 2015 and 2020 at a large integrated health system. Treatment within 45 days of a depression diagnosis was identified, including antiobesity medication and group or individual weight management visits (eg, bariatric medicine); antidepressant prescriptions; or visits with a psychologist, social worker, or psychiatrist. Patients were grouped into treatment groups: none, depression only, weight management only, or both. Generalized structural equation models were used to identify the association between treatment group and body mass index change at 6 and 12 months, accounting for demographic and health characteristics as fixed variables and clinician identifier as a random variable.

Results: Of the 13,729 adults, 43% received depression treatment, 3% received weight management treatment, and 4% received both. Individuals who received weight management treatment only lost more weight at 6 months (β = −1.0 kg/m2) and 12 months (β = −1.07 kg/m2) than individuals with no treatment. Individuals who had both treatments lost more weight than individuals with depression treatment alone (6 months: β = −1.07 kg/m2; 12 months: β = −1.21 kg/m2) and underwent a similar average change than those who received weight management treatment alone (P > 0.05).

Conclusions: There is an opportunity to increase treatment for obesity among patients with newly diagnosed depression.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Docherty AR. Leveraging psychiatric and medical genetics to understand comorbid depression and obesity. Br J Psychiatry J Ment Sci 2017;211:61–62.
 
2. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010;67:220.
 
3. Rivera M, Locke AE, Corre T, et al. Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals. Br J Psychiatry 2017;211: 70–76.
 
4. Pfoh ER, Janmey I, Anand A,et al. The impact of systematic depression screening in primary care on depression identification and treatment in a large health care system: a cohort study. J Gen Intern Med 2020;35:3141–3147.
 
5. Siu AL, US Preventive Services Task Force; Bibbins-Domingo K, et al. Screening for depression in adults: US Preventive Services Task Force recommendation statement. JAMA 2016;315:380–387.
 
6. Paulose-Ram R, Safran MA, Jonas BS, et al.Trends in psychotropic medication use among U. S. adults. Pharmacoepidemiol Drug Saf 2007;16:560–570.
 
7. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009;66:848–856.
 
8. Bhattacharjee S, Al Yami M, Kurdi S, et al. Prevalence, patterns and predictors of depression treatment among community-dwelling older adults with stroke in the United States: a cross sectional study. BMC Psychiatry 2018;18:130.
 
9. Uguz F, Sahingoz M, Gungor B, et al. Weight gain and associated factors in patients using newer antidepressant drugs. Gen Hosp Psychiatry 2015;37:46–48.
 
10. Blumenthal SR, Castro VM, Clements CC, et al. An electronic health records study of long-term weight gain following antidepressant use. JAMA Psychiatry 2014;71: 889–896.
 
11. Zheng Y, Manson JE, Yuan C, et al. Associations of weight gain from early to middle adulthood with major health outcomes later in life. JAMA 2017;318:255–269.
 
12. Verhaegen AA, VanGaal LF. Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options. JEndocrinolInvest2017;40: 1165–1174.
 
13. Yu YH, Vasselli JR, Zhang Y, et al. Metabolic vs. hedonic obesity: a conceptual distinction and its clinical implications. Obes Rev Off J Int Assoc Study Obes 2015;16: 234–247.
 
14. Karyotaki E, Efthimiou O, Miguel C, et al. Internet-based cognitive behavioral therapy for depression: a systematic review and individual patient data network meta-analysis. JAMA Psychiatry 2021;78:361–371.
 
15. Angstman KB, Wade TW, Dejesus RS, et al. Patient’s weight 6 months after depression treatment is not affected by either clinical remission or enrolment in collaborative care management. Ment Health Fam Med 2013;10:15–21.
 
16. Fuller NR, Burns J, Sainsbury A, et al. Examining the association between depression and obesity during a weight management programme. Clin Obes 2017;7:354–359.
 
17. Ma J, Rosas LG, Lv N, et al. Effect of integrated behavioral weight loss treatment and problem-solving therapy on body mass index and depressive symptoms among patients with obesity and depression: the RAINBOW randomized clinical trial. JAMA 2019;321: 869–879.
 
18. US Preventive Services Task Force; Curry SJ, Krist AH, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement. JAMA 2018;320:1163–1171.
 
19. Pfoh ER, Heinberg LJ, Rothberg MB. Factors impacting physician referral to and patient attendance at weight management programs within a large integrated health system. J Gen Intern Med 2021;36:2339–2345.
 
20. Callahan CM, Nienaber NA, Hendrie HC, et al. Depression of elderly outpatients: primary care physicians’ attitudes and practice patterns. J Gen Intern Med 1992;7:26–31.
 
21. Sweeten G. Group-based trajectory models. In: Bruinsma G, Weisburd D, eds., Encyclopedia of Criminology and Criminal Justice. New York: Springer; 2014:1991–2003.
 
22. Nagin DS, Jones BL, Passos VL, et al. Group-based multi-trajectory modeling. Stat Methods Med Res 2018;27:2015–2023.
 
23. Nagin DS. Group-based trajectory modeling: an overview. Ann Nutr Metab 2014;65: 205–210.
 
24. Tápias FS, Otani VHO, Vasques DAC, et al. Costs associated with depression and obesity among cardiovascular patients: medical expenditure panel survey analysis. BMC Health Serv Res 2021;21:433.
 
25. Gafoor R, Booth HP, Gulliford MC. Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study. BMJ 2018;361:k1951.
 
26. Wium-Andersen MK, Wium-Andersen IK, Prescott EIB, et al. An attempt to explain the bidirectional association between ischaemic heart disease, stroke and depression: a cohort and meta-analytic approach. Br J Psychiatry. 2020;217:434–441.
 
27. Morriss R, Tyrer F, Zaccardi F, et al. Safety of antidepressants in a primary care cohort of adults with obesity and depression. PLoS One 2021;16:e0245722.
 
28. Ely AC, Greiner KA, Born W, et al. Concordance of patient-physician obesity diagnosis and treatment beliefs in rural practice settings. J Rural Health 2006;22:364–366.
 
29. Greiner KA, Born W, Hall S, et al. Discussing weight with obese primary care patients: physician and patient perceptions. J Gen Intern Med 2008;23:581–587.
 
30. Bleich SN, Huizinga MM, Beach MC, et al. Patient use of weight-management activities: a comparison of patient and physician assessments. Patient Educ Couns 2010;79: 344–350.
 
31. Pickett-Blakely O, Bleich SN, Cooper LA. Patient-physician gender concordance and weight-related counseling of obese patients. Am J Prev Med 2011;40:616–619.
 
32. Stanners MN, Barton CA, Shakib S, et al. Depression diagnosis and treatment amongst multimorbid patients: a thematic analysis. BMC Fam Pract 2014;15:124.
 
33. House TW. Fact sheet: Biden-Harris administration takes action to make it easier to access in-network mental health care. https://www.whitehouse.gov/briefing-room/statements-releases/2023/07/25/fact-sheet-biden-harris-administration-takes-action-to-make-it-easier-to-access-in-network-mental-health-care. Published July 25, 2023. Accessed August 16, 2023.
 
34. Lewis KH, Edwards-Hampton SA, Ard JD. Disparities in treatment uptake and outcomes of patients with obesity in the USA. Curr Obes Rep 2016;5:282–290.
 
35. Gill H, Gill B, El-Halabi S, et al. Antidepressant medications and weight change: a narrative review. Obesity (Silver Spring) 2020;28:2064–2072.